Research status of microwave ablation combined with TKI molecular targeted therapy for non-small cell lung cancer
LIU Beibei
CHEN Junhui
MA Chunzheng
LI Dongdong
GUO Junhui
Abstract：As a malignant tumor with high incidence and high mortality,lung cancer poses a serious threat to human health.Although surgery,radiotherapy,chemotherapy,immunotherapy and molecular targeting have achieved certain clinical results,the five-year survival rate of patients is still unsatisfactory.As a relatively new local treatment,microwave ablation is becoming a focus in the field of lung cancer treatment for its advantages of minimally invasive,low side effects,prolonged survival and preservation of organ integrity.This paper aims to summarize the synergic therapeutic effect of microwave ablation combined with Osimertinib,to analyze its clinical benefits,especially the influence of combined use of Osimertinib,and to forecast the potential of microwave ablation technology combined with molecular targeted drugs in the future.
Keywords：Microwave ablationMolecular targeted drugsNon-small cell lung cancerSummary
Publication Date：2024-08-20
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：6( 411-416 )